Joey Fortuna | Researcher Profile | Sotabase

Career

· CTO, J2 Global, Inc. (now Ziff Davis, Inc.)2018–

· CTO, Ziff Davis, Inc.2011–

· Senior Vice President of Engineering, VINDICO Group2010–2011

· Vice President of Engineering, Quigo Technologies, Inc.2007–2008

· Master's Degree in Computer Science, Columbia University

· Bachelor's degree, Georgetown University

· Co-founder and Vice President of Technology, Pseudo Programs, Inc.

Publications (35)

Concomitant mobilization of plasma cells and hematopoietic progenitors into peripheral blood of multiple myeloma patients: positive selection and transplantation of enriched CD34+ cells to remove circulating tumor cells.

Blood · 1996

187

cited

Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.

Blood · 1997

123

cited

Generation and functional characterization of human dendritic cells derived from CD34+ cells mobilized into peripheral blood: comparison with bone marrow CD34+ cells

British Journal of Haematology · 1998

cited

Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.

Experimental Hematology · 1993

cited

Expression and functional role of c‐kit ligand (SCF) in human multiple myeloma cells

British Journal of Haematology · 1994

cited

Effects of hormone replacement therapy on C-reactive protein levels in healthy postmenopausal women: comparison between oral and transdermal administration of estrogen.

American Journal of Medicine · 2002

cited

Interleukin-9 stimulates the proliferation of human myeloid leukemic cells.

Blood · 1996

cited

Concomitant Mobilization of Plasma Cells and Hematopoietic Progenitors into Peripheral Blood of Patients with Multiple Myeloma

Journal of Hematotherapy · 1996

cited

Selection and transplantation of autologous hematopoietic CD34+ cells for patients with multiple myeloma.

Leukemia and Lymphoma · 1997

cited

T cell alloreactivity induced by normal G-CSF-mobilized CD34+ blood cells

Bone Marrow Transplantation · 1998

cited

Cycling Status of CD 34 " Cells Mobilized Into Peripheral Blood of Healthy Donors by Recombinant Human Granulocyte Colony-Stimulating Factor

1997

cited

Pharmacological purging of minimal residual disease from peripheral blood stem cell collections of acute myeloblastic leukemia patients: preclinical studies.

Experimental Hematology · 1997

cited

Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.

Experimental Hematology · 1994

cited

Concomitant and sequential administration of recombinant human granulocyte colony-stimulating factor and recombinant human interleukin-3 to accelerate hematopoietic recovery after autologous bone marrow transplantation for malignant lymphoma.

Journal of Clinical Oncology · 1996

cited

Positive selection of hematopoietic CD34+ stem cells provides 'indirect purging' of CD34- lymphoid cells and the purging efficiency is increased by anti-CD2 and anti-CD30 immunotoxins.

Bone Marrow Transplantation · 1994

cited

Induction of "in vitro" apoptosis by fludarabine in freshly isolated B-chronic lymphocytic leukemia cells.

Leukemia and Lymphoma · 1994

cited

Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.

Haematologica · 1998

cited

C-kit ligand (SCF) in human multiple myeloma cells.

Leukemia and Lymphoma · 1996

cited

Interleukin‐11 (IL‐11) acts as a synergistic factor for the proliferation of human myeloid leukaemic cells

British Journal of Haematology · 1995

cited

Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.

Experimental Hematology · 1995

cited

Sotabase